Inside (the Beltway) Scoop

By Jennifer Zeitzer and Meghan McCabe Congress Adjourns for Summer Break; Senate Releases Text of NIH Funding Bill; Hearings Examine Medical Breakthroughs and the Federal Research Portfolio Congress will adjourn for its summer break at the end of this week, leaving a lot of unfinished legislative business to be resolved later this fall. When lawmakers […]

NIGMS Requests Feedback on Pilot Program to Fund “People” Versus “Projects”

By Yvette Seger Earlier this month, the National Institute of General Medical Sciences (NIGMS) released a Request for Information (RFI) seeking public input on a proposal to test a new program that would provide greater, longer-term financial support for the spectrum of research within the laboratory of a Principal Investigator (PI). The program, Maximizing Investigators’ […]

Society Spotlight: The Biomedical Engineering Society

By Allison Lea The Biomedical Engineering Society (BMES) is a rapidly growing society with over 6,500 members. As the lead society for biomedical engineering and bioengineering, BMES strives to promote and enhance knowledge and education in the field and its utilization for human health and well-being worldwide. The Society charters and supports more than 100 […]

Capitol Hill Briefing Highlights Million Veteran Program

By Ashley Parker On July 13, the Friends of Veterans Affairs Medical Care and Health Research (FOVA) sponsored a briefing to discuss the advances, challenges, and future direction of the Million Veteran Program (MVP). Jennifer Zeitzer, the Director of Legislative Affairs at the Federation of American Societies for Experimental Biology (FASEB) moderated the briefing. The […]

New Yorker Article on the Journey to Diagnose a Rare Disease Mentions Contribution of FASEB’s Vice President for Science Policy

By Allison Lea An extremely compelling story about a family’s desperate struggle to find help for their seriously ill child, “One of a Kind,” appeared in the July 21 issue of The New Yorker. Science writer Seth Mnookin describes the Might family and their frustrating search for answers to their son Bertrand’s debilitating rare disease. […]